<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01325649</url>
  </required_header>
  <id_info>
    <org_study_id>Ocumstudy 19.08.2009</org_study_id>
    <nct_id>NCT01325649</nct_id>
  </id_info>
  <brief_title>Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma</brief_title>
  <acronym>OCUM</acronym>
  <official_title>Optimal Surgery With Total Mesorectal Excision and MRI Based Multimodal Therapy of Rectal Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to provide proof that a MRI based preoperative
      radiochemotherapy in patients with locally advanced rectal carcinoma allows limiting RCT to
      high risk patients without increase of locoregional recurrence rate and decrease of overall
      survival provided there is a high quality of mesorectal excision.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The criteria for application of RCT is the distance of the tumor from mesorectal fascia in
      preoperative MRI of the pelvis. In case of a T 4 tumor or a tumor with a distance of 1mm of
      less form mesorectal fascia long-course radiochemotherapy is applied followed by surgery, in
      all other cases primary surgery is done.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Locoregional recurrence rate</measure>
    <time_frame>Five year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of involvement of circumferential resection margin (pCRM positive of resected specimens</measure>
    <time_frame>postoperative</time_frame>
    <description>pCRM positive means a distance of the tumor from circumferential resection margin 1mm or less.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1051</enrollment>
  <condition>Rectal Cancer Stage II</condition>
  <condition>Rectal Cancer Stage III</condition>
  <arm_group>
    <arm_group_label>advanced rectal cancer</arm_group_label>
    <description>Patients with carcinoma of the middle rectum with positive mrCRM (≤ 1 mm), with cT3 low rectal carcinoma, and with cT4 Tumors Arm 1 Long course radiochemotherapy before total mesorectal excision Arm 2 total mesorectal excision without radiochemotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>total mesorectal excision / long course radiochemotherapy</intervention_name>
    <description>long course 5-FU based radiochemotherapy before total mesorectal excision</description>
    <arm_group_label>advanced rectal cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>long course 5-FU bases radiochemotherapy</intervention_name>
    <arm_group_label>advanced rectal cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with carcinoma of the middle rectum with positive mrCRM (≤ 1 mm), with cT3 low
        rectal carcinoma, and with cT4 tumors
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with histologically confirmed invasive carcinoma of the rectum infiltrating
             beyond the submucosa (cT3, cT2N+, cM0)

          -  Elective surgery

          -  Fit for surgery

          -  Preoperative MRI of pelvis

        Exclusion Criteria:

          -  uT1 Tumors

          -  provided for local excision

          -  previous or synchronous malignant tumors (except squamous and basal cell carcinoma of
             the skin and carcinoma in situ of the cervix)

          -  previous irradiation of the pelvis

          -  ulcerative colitis or Crohn's disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Medicine Center Department of General and Abdomial Surgery</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2011</study_first_submitted>
  <study_first_submitted_qc>March 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2011</study_first_posted>
  <last_update_submitted>October 18, 2016</last_update_submitted>
  <last_update_submitted_qc>October 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Theo Junginger</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>rectal cancer</keyword>
  <keyword>MRI</keyword>
  <keyword>selective preoperative radiochemotherapy</keyword>
  <keyword>involvement of circumferential resection margin</keyword>
  <keyword>locoregional recurrence rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

